CARDIOME PHARMA
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.
CARDIOME PHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
1986-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.cardiome.com
Total Employee:
51+
Status:
Active
Contact:
1231231234
Total Funding:
57.01 M USD
Technology used in webpage:
SPF Google Font API Font Awesome Microsoft Exchange Online Office 365 Mail JsDelivr Cloudflare JS CDN JS GoDaddy DNS JQuery CDN
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-11-19 | Correvio | Correvio acquired by Cardiome Pharma | N/A |
Investors List
CRG
CRG investment in Post-IPO Debt - Cardiome Pharma
Official Site Inspections
http://www.cardiome.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
